Integrative Program Officer, David H. Koch Institute for Integrative Cancer Research at MIT
Mr. Lee co-founded Lumicell Inc and remains the CEO. Lumicell has developed a proprietary imaging agent and hand-held detector to guide surgeons to microscopic cancer during cancer surgery. The company has received its IDE approval from The FDA and is entering the final clinical trial. Mr. Lee also has a research appointment at the MIT Koch Institute for Integrative Cancer Research where he advises on the translation from concept to clinical use of new technologies. Prior to his role at MIT David was the Senior Vice President of Arthur D. Little, Inc for Technology and Product Development, which was one of the three lines of business of the company.
David has his undergraduate and graduate degrees from MIT and holds numerous patents.